Neonatal hypotension survey : a South African perspective by Van Wyk, L. et al.
73        SAJCH     JUNE 2019    Vol. 13    No. 2
RESEARCH
Neonatal hypotension remains one of the most controversial topics 
in neonatology. The physiological range of blood pressure (BP) 
that ensures adequate tissue perfusion in neonates is unknown.The 
clinical significance of BP measurements remains controversial[1] as 
it is well known that BP does not equate to systemic blood flow.[2]
Various definitions for neonatal hypotension are used: (i) mean 
BP less than the gestational age (in weeks);[3] (ii) mean BP less 
than 30 mmHg;[4] and (iii) systolic and diastolic BP below the 10th 
centile for age.[5] These references are based on very little research, 
with the averaging of BP data over wide time periods, inclusion 
of appropriate for gestational age (AGA) and small for gestational 
age (SGA) infants, a combination of invasive and non-invasive 
BP measurements, and small numbers of patients.[6] BP below the 
gestational age (GA) remains one of the most common definitions 
used, despite no research to substantiate its use (Table 1).
Studies comparing different definitions have not been able to show 
superiority of one definition above another.[7] Varying definitions 
have led to varying inclusion criteria for research trials, leading to 
uncertainty in evidence-based clinical practice.
Clinical signs[8] and echocardiographic investigation[9] have been 
suggested as supplementary and alternative diagnostic methods to 
determine whether a low BP requires intervention.
Optimal management of neonatal hypotension is unclear despite 
widespread pharmacological manipulation of neonatal BP,[10] with 
minimal evidence of improved short- or long-term outcomes.[11]
No intervention (volume expansion,[11] dopamine, dobutamine,[12] 
adrenaline[13]) has been shown to positively affect short-term 
outcomes, despite these remaining the most common interventions 
in neonatal hypotension.
It is unclear whether hypotension per se,[14] its definition[7] or its 
treatment[15] are associated with abnormal neurological outcomes. 
Inotropes have also been shown to adversely affect amplitude 
integrated electroencephalography (aEEG)[16] as well as variably 
affecting cerebral regional oxygen saturation (CrSO2).
[17,18]
It remains unclear what the aim of BP management is – prevention 
of mortality, improved cerebral and systemic blood flow, or the 
prevention of long-term adverse neurodevelopmental outcomes. 
The aim of the present research was to determine (i) the diagnostic 
criteria for neonatal hypotension and (ii) management strategies for 
neonatal hypotension in South Africa.
Method
A 29-point questionnaire was designed to determine the criteria used 
by South African neonatologists and paediatricians to diagnose and 
manage neonatal hypotension.
The survey was conducted by two means: (i) a web-accessible 
survey (www.surveymonkey.com) was sent via an email link to 
clinicians (February - April 2017) with monthly reminders. Clinicians 
(paediatricians and neonatologists) were identified from university 
email lists, clinician management groups (Paediatric Management 
Group(PMG)) and MedPages; and (ii) a paper-based survey was 
conducted at a South African national neonatal congress (USANA, 
Durban, September 2017).
Responses to the web- and paper-based surveys were considered 
as consent to participate in the research. For the web survey, 
confidentiality was maintained by providing a web-accessible survey 
as well as an email link to the survey. Email and IP (internet 
protocol) addresses were not recorded. For the paper-based survey, 
confidentiality was maintained by anonymous placing of the survey 
in a sealed box at the congress. In neither survey were any personal, 
identifiable data collected.
The research was approved by the Health Research Ethics 
Committee of the University of Stellenbosch, South Africa (ref. no. 
N17/01/003).
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Statistical analysis was performed using 
MedCalc Statistical Software version 17.6. 




For the electronic survey, 512 electronic 
questionnaires were distributed and 52 
completed questionnaires were received 
– 5 questionnaires were eliminated (4 
respondents did not treat hypotension; 1 
partial response). This represented a 9.2% 
(47/512) response rate.
For the paper-based survey, 135 
questionnaires were distributed and 111 
were returned. Eighty-five completed 
questionnaires were available for analysis 
(11 were incomplete and 15 marked ‘nursing 
personnel’ were excluded). This equated to a 
response rate of 70.8% (85/120).
The combination of the 2 surveys 
resulted in a 20.8% (132/632) response rate. 
Demographics of respondents are shown in 
Table 2.
Availability of monitoring and 
treatment modalities
Onsite echocardiography (57%) and 
e le c t ro encepha log raphy/ampl i tude-
integrated electroencephalography(EEG/
aEEG) (69%) were widely available, with 
various other modalities less available: 
central venous pressure (CVP) monitoring 
(40%), perfusion index (5%), and near-
infrared spectroscopy (NIRS) (4%). 
Clinicians considered echocardiography 
useful in determining initial therapeutic 
intervention (34%) and to change initial 
management (34%).
Dopamine, dobutamine and adrenaline were 
available to all respondents. Vasopressin, 
noradrenaline and milrinone were less 
available (22%, 23% and 36%, respectively).
Criteria for diagnosing neonatal 
hypotension
Most clinicians (76%) used a BP below the 
gestational age (in weeks) as a criterion 
to diagnose neonatal hypotension. All 
respondents used clinical and biochemical 
parameters, in combination, to diagnose 
hypotension. Most clinicians (67%) 
considered a low BP, independent of other 
diagnostic modalities, to be sufficient to 
diagnose neonatal hypotension (Table 3).
When escalating hypotension therapy, most 
clinicians (75%) utilised a combination of BP, 
clinical signs and laboratory values. Only 
15% of clinicians utilised echocardiography 
to escalate or change antihypotensive therapy.
Neonatal hypotension management
Most clinicians (86%) administered fluid 
prior to initiating inotrope therapy. A volume 
of 20 mL/kg was administered by most 
respondents (79%) with 12% of clinicians 
administering more than 30 mL/kg prior to 
initiating inotropes. Crystalloid fluids were 
most commonly used (87%).
Dopamine was the most common first-
line inotrope (71%), with dobutamine (23%) 
and adrenaline (6%). Dobutamine (57%) and 
adrenaline (47%) were the most common 
second and third line anti-hypotensive 
drugs used, respectively. The most common 
antihypotensive combination was dopamine, 
dobutamine and adrenaline as first-, 
second- and third- line, respectively (Fig. 1). 
Adrenaline was not used by 14% of clinicians. 
Steroid choice and dose were not surveyed.
Inotropic drug choice would not be 
changed by 66% of repondents, irrespective 
Table 1. Neonatal hypotension definitions: International comparison
Reference
Geographical 
location n/response rate Definition Management




216 (not stated) 73%: MAP<GA
60%: circulation assessment additional
80% consider using permissive 
hypotension
85%: volume as initial intervention
62%: dopamine 1st line
45.6%: volume+dopamine+dobutamine
48.1%: dopamine + other inotrope
Bhojani et al. 
2010[20]
UK 82/86% 73%: BP<GA
4%: reference charts
16%: GA and reference
90%: fluid bolus as initial intervention
10%: dopamine 1st line
65%: dopamine 2nd line
65%: dobutamine 3rd line
70%: steroids as 4th line
20%: adrenaline as 4th line
Dempsey et al. 
2006[21]
Canada 93/79% 82%: BP<GA
3%: BP<30mmHg
Rest: reference standards 
32%: dopamine + steroid
29% volume, dopamine, dobutamine
22%: volume, dopamine, epinephrine
Sehgal et al. 
2012[22]
Australia/NZ 114/65% 91%: mean BP (no definition)
60.6%: clinical/laboratory values (lactate, 
BE, metabolic acidosis)
24.5%: echocardiography
35%: additional fluid bolus
28%: dopamine infusion as 1st line
17%: dopamine 1st line
3%: adrenaline as 3rd line
39%: hydrocortisone as 4th line
BE = base excess; GA = gestational age; MAP = mean arterial pressure; NZ = New Zealand.
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Table 2. Demographics of questionnaire respondents
Demographic variable Option n (%) (N=132)
Specialist level Paediatrician 80 (61)
Neonatologist 52 (39)
Neonatal experience level <5 years 28 (21)
5 - 10 years 34 (26)
>10 years 70 (53)
Hospital affiliation Public health sector 56 (42)
Private health sector 76 (58)
Province (location of hospital) Eastern Cape 6 (5)





Northern Cape 2 (1.5)
North West 1 (1)
Western Cape 40 (30)
Level NICU available Level 1 9 (7)
Level 2 (high care) 36 (27)
Level 3 (ventilator-capable)* 87 (66)
Annual VLBW admissions <50 per year 34 (26)
51 - 99 22 (17)
>100 76 (58)
Number of NICU beds <5 26 (20)
6 - 10 66 (50)
11 - 20 35 (27)
>21 5 (3)
NICU = neonatal intensive care unit; VLBW = very low birthweight.
*Level 3 (ventilator-capable) implies the ability to provide life-supporting care, i.e. invasive ventilation capability.
Table 3. Criteria for neonatal hypotension diagnosis
Item Option n (%) (N=132)
Hypotension diagnosis BP <GA in weeks 99 (75)
BP < 30 mmHg 11 (9)
BP <10th centile 21 (16)
Clinical signs utilised in diagnosis of hypotension BP only 13 (10)
Capillary refill >3 s 92 (70)
Capillary refill >4 s 14 (11)
Oliguria <1 mL/kg/h 56 (42)
Oliguria <0.5 mL/kg/h 41 (31)
Poor colour 65 (49)
Temperature differential 21(16)
Tachycardia 80 (61)
Metabolic acidosis 98 (74)
Increased serum lactate 85 (64)
Other useful diagnostic modalities prior to initiating antihypotensive therapy None – BP only 88 (67)
CVP 9 (7)
Echocardiographic parameters 22 (17)
Perfusion index 6 (5)
Mixed venous saturation 6 (5)
Heart rate variability 23 (17)
aEEG 6 (5)
NIRS 3 (2)
aEEG = amplitude-integrated electroencephalography; BP = blood pressure; CVP = central venous pressure; GA = gestational age; NIRS = near infrared spectroscopy.
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of whether the neonate was term or preterm. Reasons provided for 
different inotrope choices were stated as the presence of hypoxic-
ischaemic encephalopathy, persistent pulmonary hypertension and 
the age of onset of hypotension.
Hypotension management guidelines were not used by 77% of 
respondents. Varying hypotension management guidelines were 
used by 23% of clinicians: in-house guidelines (88%), American 
Academy of Pediatrics guidelines (3%) and other international 
hospital neonatal guidelines (6%).
Aim of hypotension management
The aim of hypotension treatment was stated to be: prevention of 
morbidity (61%), reduction of mortality (62%), increase BP (24%), 
and increase cardiac output (48%). Some clinicians (18%) stated that 
hypotension treatment was appropriate management according to 
neonatal consensus.
Discussion
The present study is the first to report on the diagnostic criteria and 
management of neonatal hypotension in South Africa. Respondent 
demographics reflect the state of medicine in South Africa. Survey 
respondents were mostly paediatricians, employed in the private 
sector, and originating from Gauteng and Western Cape provinces.
Very low birth weight (VLBW) infant admission numbers were 
high[23] (55% of respondents having >100 admissions per annum) 
and in keeping with the VLBW rate (3.04 per 1 000 live births)[24] in 
South Africa. The availability of NICU beds per unit was generally 
low (6 - 10 beds per unit) but is in keeping with the management of 
most neonates in high-care units as well as the designation of NICU 
bed applicable only to beds with invasive ventilation capability.
Despite a significant lack of evidence and research to support any 
specific neonatal hypotension definition, the most commonly used 
is a BP less than the gestational age (in weeks).This trend was also 
seen in this survey (Table 3) and is similar to international studies’ 
results (Table 1). Published normative data exist for systolic, diastolic 
and mean BP in neonates of various gestational ages, birth weights 
and postnatal ages.[25,26] These data, however, are not utilised and 
not reflected in the Standard Treatment Guidelines and Essential 
Medicines List for South Africa (mean BP at least 5 - 10 mmHg above 
the mean gestational age (in weeks)).[27]
Very few survey respondents used a hypotension guideline, 
which underscores the international lack of clear diagnostic 
and management guidelines regarding neonatal hypotension 
management. Comments left by respondents seem to reinforce this 
concept: ‘more guidance would be appreciated’, and ‘general lack of 
consensus and insight’.
Similar to international neonatal hypotension management studies, 
most respondents administered crystalloid fluid prior to inotrope 
initiation, despite a lack of evidence.[11] Dopamine, dobutamine 
and adrenaline were the most commonly used inotropes, similarly 
to other international studies. Also similar to other international 
studies, dopamine, dobutamine and adrenaline represented first-, 
second- and third-line therapy, despite a lack of evidence for this 
sequence of therapy.[13,28] Dopamine is the recommended inotrope 
for neonatal hypotension in the South African Standard Treatment 
Guidelines and Essential Medicines List,[27] despite insufficient 
evidence.
Steroid administration in the current survey was low compared 
with international studies (20% and 39 - 70%, respectively). The 
reason for this discrepancy is unclear but is possibly due to the lack 
of clear hypotension management guidelines and the fear of steroid 
side-effects on the preterm infant.[29]
The relatively high availability of on- and off-site echocardiography 
in a low-middle-income country, such as South Africa, is reassuring. 
However, echocardiography was considered useful for initiating or 
changing inotrope choice, and not as an initial method to diagnose 
the underlying pathophysiology of hypotension. This action is 
contrary to research showing that echocardiographic identification 
of pathophysiology may aid in therapeutic decisions.[9]
A majority of respondents stated that inotrope therapy would 
reduce morbidity and mortality. However, this is not consistently 
supported in the literature. It is unclear whether hypotension, 
irrespective of the definition used, or inotropic therapy itself, leads 
to adverse outcomes.[7] This uncertainty leads to diverse management 
strategies, thereby further compounding the uncertainty of outcomes 
and the choice of management.[30]
Study limitations
Although ours is the first published study to report on the criteria 
used by paediatricians and neonatologists for neonatal hypotension 
diagnosis and its treatment, its results and conclusions are hampered 
by the low response rate (20.4%). It is also unclear how many 
respondents completed both surveys, as identifying details were not 
collected, which may further decrease the response rate and thus the 
reliability of the study.
Data presented reflect personal choices of respondents. It is unclear 
how many responding clinicians worked in the same neonatal unit, 
as these data were not collected for ethical confidentiality reasons, 
which may influence the data interpretation.
Recommendations
South Africa uses definitions and management strategies for 
neonatal hypotension which are similar to those used by many 
international institutions. The international controversy of when 
and how to manage neonatal hypotension remains apparent in 
South Africa. More research is required to develop appropriate, 
evidence-based neonatal hypotension protocols, also in low-
resource settings, such as South Africa. These include establishing 
normative BP data for clinical use and the definition of neonatal 
hypotension.
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